Journals / Experimed / 2020 / Cilt: 10 - Sayı: Supplement 1

POSTER PROCEEDINGS

Journal
Experimed
Pages
23–36
Publication Date
2020-03-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Omics Technologies in Life Sciences: From Genome to Therapy Yaşam Bilimlerinde Omik Teknolojileri: Genomdan Tedaviye

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Omics Technologies in Life Sciences: From Genome to Therapy Yaşam Bilimlerinde Omik Teknolojileri: Genomdan Tedaviye
📊
Key Findings & Data:Omics Technologies in Life Sciences: From Genome to Therapy Yaşam Bilimlerinde Omik Teknolojileri: Genomdan Tedaviye
💡
Conclusion & Impact:Omics Technologies in Life Sciences: From Genome to Therapy Yaşam Bilimlerinde Omik Teknolojileri: Genomdan Tedaviye
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:POSTER PROCEEDINGS · POSTER SUNUMLARI · AZIZ SANCAR INSTITUTE OF EXPERIMENTAL MEDICINE DAYS

Abstract

Omics Technologies in Life Sciences: From Genome to Therapy Yaşam Bilimlerinde Omik Teknolojileri: Genomdan Tedaviye

🔖

Cite This Article

ÇAKMAKOĞLU, B. (2020). POSTER PROCEEDINGS. Experimed, Cilt: 10 - Sayı: Supplement 1, 23–36. https://ajindex.com/articles/50824

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Bowman P, Flanagan SE, Edghill EL, Damhuis A, Shepherd MH, Paisey R, et. al. Heterozygous ABCC8 mutations are a cause of MODY. Diabetologia. 2012 Jan;55(1):123-7
  2. Qin LJ, Lv Y, Huang QY. Meta-analysis of association of common variants in the KCNJ11-ABCC8region with type 2 diabetes. Genet Mol Res 12.3 (2013): 2990-3002.